AR080098A2 - CRYSTALLINE POLYMORPH COMPOUND OF THE ACID COMPOUND 6- (4-CHLOROPHENYL) -2,2-DIMETHYL-7-PHENYL-2,3 DIHYDRO-1H-PIRROLIZIN-5-ILACETICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE THIS LAST AND PROCESS TO PREPARE SUCH CRYSTAL POLYMORPH - Google Patents
CRYSTALLINE POLYMORPH COMPOUND OF THE ACID COMPOUND 6- (4-CHLOROPHENYL) -2,2-DIMETHYL-7-PHENYL-2,3 DIHYDRO-1H-PIRROLIZIN-5-ILACETICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE THIS LAST AND PROCESS TO PREPARE SUCH CRYSTAL POLYMORPHInfo
- Publication number
- AR080098A2 AR080098A2 ARP110100332A AR080098A2 AR 080098 A2 AR080098 A2 AR 080098A2 AR P110100332 A ARP110100332 A AR P110100332A AR 080098 A2 AR080098 A2 AR 080098A2
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- compound
- pharmaceutical composition
- polymorph
- pirrolizin
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuesto polimorfo cristalino, de la formula (1) que tiene una unica línea endotérmica en el diagrama de DSC, que está dentro del rango que oscila entre 155 y 170°C. Composicion farmacéutica que lo comprende, su uso para preparar esta ultima y proceso para preparar dicho polimorfo cristalino. Uso del compuesto para preparar una composicion farmacéutica para el tratamiento de trastornos de tipo reumático. Reivindicacion 2: Compuesto de acuerdo con la reivindicacion 1, caracterizado porque tiene los siguientes picos significativos en el espectro IR (numero de onda, cm-1): 1706; 1601; 1536; 1487; 1463; 1450; 1441; 1413; 1395; 1383; 1369; 1293; 1219; 1177; 1099; 1013; 836; 765; 698.Crystalline polymorphic compound, of the formula (1) having a unique endothermic line in the DSC diagram, which is within the range of 155 to 170 ° C. Pharmaceutical composition comprising it, its use to prepare the latter and process to prepare said crystalline polymorph. Use of the compound to prepare a pharmaceutical composition for the treatment of rheumatic disorders. Claim 2: Compound according to claim 1, characterized in that it has the following significant peaks in the IR spectrum (wave number, cm-1): 1706; 1601; 1536; 1487; 1463; 1450; 1441; 1413; 1395; 1383; 1369; 1293; 1219; 1177; 1099; 1013; 836; 765; 698.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP110100332 AR080098A2 (en) | 2011-02-01 | 2011-02-01 | CRYSTALLINE POLYMORPH COMPOUND OF THE ACID COMPOUND 6- (4-CHLOROPHENYL) -2,2-DIMETHYL-7-PHENYL-2,3 DIHYDRO-1H-PIRROLIZIN-5-ILACETICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE THIS LAST AND PROCESS TO PREPARE SUCH CRYSTAL POLYMORPH |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP110100332 AR080098A2 (en) | 2011-02-01 | 2011-02-01 | CRYSTALLINE POLYMORPH COMPOUND OF THE ACID COMPOUND 6- (4-CHLOROPHENYL) -2,2-DIMETHYL-7-PHENYL-2,3 DIHYDRO-1H-PIRROLIZIN-5-ILACETICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE THIS LAST AND PROCESS TO PREPARE SUCH CRYSTAL POLYMORPH |
Publications (1)
Publication Number | Publication Date |
---|---|
AR080098A2 true AR080098A2 (en) | 2012-03-14 |
Family
ID=45830848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110100332 AR080098A2 (en) | 2011-02-01 | 2011-02-01 | CRYSTALLINE POLYMORPH COMPOUND OF THE ACID COMPOUND 6- (4-CHLOROPHENYL) -2,2-DIMETHYL-7-PHENYL-2,3 DIHYDRO-1H-PIRROLIZIN-5-ILACETICO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE TO PREPARE THIS LAST AND PROCESS TO PREPARE SUCH CRYSTAL POLYMORPH |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR080098A2 (en) |
-
2011
- 2011-02-01 AR ARP110100332 patent/AR080098A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY33547A (en) | CHEMICAL COMPOUNDS Bcl-2 and Bcl-XL | |
DOP2016000281A (en) | IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE TO TREAT CANCER | |
CO2018003969A2 (en) | Imidazo [4,5-c] quinolin-2-one compounds | |
CL2014001174A1 (en) | Compounds derived from [1,2,3] triazolo [4,5-d] pyrimidine and their salts, as cannabinoid receptor agonists 2; its process of obtaining; pharmaceutical composition that contains them; and its use for the treatment or prophylaxis of pain, atherosclerosis, inflammation, glaucoma, transient ischemic attack, among other diseases. | |
CL2009001066A1 (en) | Compounds derived from substituted carboxylic acid cyclopentane; lpa edg2 receptor inhibitors; pharmaceutical composition; preparation procedure; and use in the treatment of cardiovascular, inflammatory, metabolic, kidney, lung, oncological, immunological and allergy diseases, among others. | |
PE20211782A1 (en) | COMPOSITIONS OF 5-CHLORO-2-DIFLUOROMETOXIFENIL PYRAZOLOPYRIMIDINE, COMPOSITIONS AND METHODS OF USE OF THE SAME | |
CR10288A (en) | PIRAZOLES AS INHIBITORS OF THE 11-BETA-HSD1 | |
DOP2018000115A (en) | IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE IN CANCER TREATMENT | |
BR112014030795A2 (en) | compound, pharmaceutical composition, use of a compound and process for preparing a compound | |
CU24603B1 (en) | SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES USEFUL IN THE TREATMENT OF RESPIRATORY DISORDERS | |
CO7131357A2 (en) | N-aryltriazole compounds as lpar antagonists | |
CU20130036A7 (en) | TRIAZINA-OXIDAZOLES | |
CL2012003722A1 (en) | Compounds derived from naf-2-ylacetic acid; pharmaceutical composition; and use for the treatment of AIDS. | |
AR094964A1 (en) | USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PHOSFOINOSITIDE-RELATED 3-CINASE D (PI3Kd) | |
CL2012003546A1 (en) | Specific compounds 2- (3- (4-cyanonaphthalen-1-yl) pyridin-4-ylthio) -2-methylprpanoic acid, in use fromula markush; pharmaceutical composition and combination that includes it; and use of the compound and the pharmaceutical combination in the preparation of medicaments for treating diseases caused by high levels of uric acid. | |
DOP2012000263A (en) | CHEMICAL COMPOUNDS | |
UY32483A (en) | NEW BENCIMIDAZOL COMPOUNDS FOR THE TREATMENT OF RESPIRATORY SINCICIAL VIRUS | |
CR11582A (en) | HETEROCICLICAL COMPOUNDS AND THEIR USES | |
CO6771439A2 (en) | Benzodioxane inhibitors of leukotriene production | |
ECSP13012519A (en) | BENZAMIDA SUBSTITUTED COMPOUNDS | |
UY31885A (en) | DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS. | |
EA201300862A1 (en) | INHIBITION OF IL17 AND IFN-GAMMA FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION | |
BR112014012358A2 (en) | 2-oxo-1,3-dioxolane-4-carboxamides, their preparation and use | |
UY32622A (en) | NEW COMPOUNDS FOR THE TREATMENT OF PATHOLOGIES RELATED TO AB (BETA) | |
AR102981A1 (en) | INHIBITORS OF CELL NECROSIS AND METHODS OF PREPARATION OF THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |